Online, direct-to-consumer access to insulin: patient safety considerations and reform
| Autor: | Tim K. Mackey, Bryan A. Liang, Kimberly M. Lovett |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Pharmaceutical Services
Online medicine.medical_specialty Prescription Drugs Prescription Drug Misuse Endocrinology Diabetes and Metabolism medicine.medical_treatment Population Biomedical Engineering Bioengineering Pharmacology Patient safety Advertising Internal Medicine medicine Humans Hypoglycemic Agents Insulin Medical prescription education Health policy education.field_of_study business.industry United States Food and Drug Administration Public health medicine.disease Underinsured United States Commentary Medical emergency Patient Safety business |
| Zdroj: | Journal of diabetes science and technology. 6(6) |
| ISSN: | 1932-2968 |
| Popis: | The online, direct-to-consumer (DTC) medical marketplace is proliferating more rapidly than regulation is evolving to ensure proper patient safety and public health controls. Along with this growing body of unrestrained medical testing and pharmaceuticals offered DTC online, most types of insulin and insulin administration products may now be purchased without prescriptions or physician guidance. Given the relatively significant risks of insulin use, the abuse potential, the high prevalence of diabetes mellitus, and the rising population of uninsured and underinsured, it is imperative to reform the online DTC medical marketplace to ensure that patient safety and public health are protected. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|